Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Ashani Weeraratna on Aging and Melanoma

Ashani Weeraratna, PhD
Published: Monday, Dec 14, 2015



Ashani Weeraratna, PhD, associate professor, Tumor Microenvironment and Metastasis Program, member, The Wistar Institute Melanoma Research Center, discusses a study examining the effects of aging on Wnt/ß-catenin signaling in melanoma.

In her current research, Weeraratna has been studying the effects of aging on skin and how tumors undergo changes in response to aging skin.

A recent study has shown that as fibroblast in skin ages, it generates secretions or stops secreting. In turn, this promotes tumor progression and creates changes in the Wnt/ß-catenin signaling pathway. These changes in tumor cells allow the tumor to become metastatic and more resistant to targeted therapies. Mechanically, changes in the collagen and extracellular matrix also occur when skin ages, which promote signaling changes.


Ashani Weeraratna, PhD, associate professor, Tumor Microenvironment and Metastasis Program, member, The Wistar Institute Melanoma Research Center, discusses a study examining the effects of aging on Wnt/ß-catenin signaling in melanoma.

In her current research, Weeraratna has been studying the effects of aging on skin and how tumors undergo changes in response to aging skin.

A recent study has shown that as fibroblast in skin ages, it generates secretions or stops secreting. In turn, this promotes tumor progression and creates changes in the Wnt/ß-catenin signaling pathway. These changes in tumor cells allow the tumor to become metastatic and more resistant to targeted therapies. Mechanically, changes in the collagen and extracellular matrix also occur when skin ages, which promote signaling changes.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Publication Bottom Border
Border Publication
x